ArticleOncotarget2019

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer.

Sierra A Colavito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.